Harbour BioMed
Michael Lee currently serves as the Senior Vice President and Head of Biometics at Harbour Biomed since February 2019. Prior to this role, Michael held the position of Director at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2005 to February 2019. Additionally, Michael was an Adjunct Assistant Professor at UMDNJ from September 2005 to May 2009 and worked as a Senior Biometrician at Merck from January 1996 to July 2005. Michael's academic credentials include a Doctor of Philosophy in Biostatistics from UCLA, a Master of Science in Statistics from the University of Southern California, and a Bachelor of Science in Mathematics from Peking University, complemented by further studies at Tsinghua University.
This person is not in any teams
This person is not in any offices
Harbour BioMed
1 followers
Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery - the H2L2 and the HCAb.